UCL spinout tackling eye disease announces £57m launch
Tenpoint

UCL spinout tackling eye disease announces £57m launch

Tenpoint Therapeutics, which spun out of UCL in 2021, has announced its launch to address degenerative eye diseases.

Accelerating dementia drug discovery
Technology and licensing image

Accelerating dementia drug discovery

AstronauTx is a biotech company that builds on research from the Alzheimer's Research UK UCL Drug Discovery Institute (DDI). Launched in 2019, it has attracted £7.5 million of investment. 

UCL Brain Sciences spinout is advancing gene therapy treatments
eye closeup

UCL Brain Sciences spinout is advancing gene therapy treatments

Research originating from the Department of Genetics at the UCL Institute of Ophthalmology hopes to treat devastating eye diseases that cause blindness.